Calycosin had significant ameliorative effects on diabetes‐induced renal inflammation by inhibiting NF‐kB‐dependent signaling in in vivo and in vitro experiments (Zhang et al. 2019). This evidence concerns the gene NFKB1 and diabetes mellitus.